Biotech

All Articles

Aligos trumpets period 2 MASH gain, reducing liver body fat up to 46%

.Aligos Therapies is actually proclaiming a midstage win in metabolic-dysfunction connected steatohe...

Basilea scores $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has actually obtained a notable boost fr...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Having already gathered up the USA civil liberties to Capricor Rehabs' late-stage Duchenne muscle d...

FDA scraps adcomm for Applied's uncommon disease medication

.After pushing back the selection meeting for Applied Therapeutics' metabolic ailment medicine govor...

Novo inks $600M NanoVation package to study genetic drugs ex-liver

.Novo Nordisk is actually continuing its own push right into genetic medicines, accepting compensate...

Innovent links cytokine to intestines cancer reactions

.Innovent Biologics has actually created the situation that its own checkpoint inhibitor-cytokine bl...

Merck, Daiichi ADC hits target in stage 3 lung cancer study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina grows artificial intelligence concentrate with collab to choose cancer intendeds

.Five months after Rakovina Rehabs turned towards expert system, the cancer-focused biotech has actu...

Ascendis' dwarfism drug smash hits in phase 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a possible threat to BioMarin's Voxzogo, disclosing period ...

Despite ph. 3 miss, Alkeus sees course ahead for eye health condition possession

.Though Alkeus Pharmaceuticals' oral eye condition resource stopped working to significantly minimiz...